Position in A
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$929
+$18 QoQ
Shares Held
7
-12.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,085
of 1,112 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Dunhill Financial, LLC holds $612,496 across 21 Diagnostics & Research names. A ranks #9 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,162 | $411,817 | |
| 2 | WAT |
Waters Corp /De/
|
199 | $74,632 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
122 | $61,165 | |
| 4 | DGX |
Quest Diagnostics Inc
|
218 | $46,205 | |
| 5 | NTRA |
Natera, Inc.
|
25 | $6,786 | |
| 6 | ILMN |
Illumina, Inc.
|
20 | $3,516 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
5 | $2,632 | |
| 8 | LH |
Labcorp Holdings Inc.
|
8 | $2,240 |
All Filings in A
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $929 | 7 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $911 | 8 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $3,809 | 28 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,208 | 25 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,068 | 26 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $8,188 | 70 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $10,478 | 78 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $9,057 | 61 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $4,148 | 32 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $3,783 | 26 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $3,058 | 22 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||